RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
OncoSec Medical Stock

OncoSec Medical Employees 2024

OncoSec Medical Employees

42

Ticker

ONCS

ISIN

US68234L3069

WKN

A2PKW3

In 2024, OncoSec Medical employed 42 people, a 0% change from the 42 number of employees in the previous year.

OncoSec Medical Aktienanalyse

What does OncoSec Medical do?

OncoSec Medical Inc is a US-based company specializing in the development of cancer treatment methods through immunotherapy. The company was founded in 2011 and is headquartered in San Diego, California. The history of OncoSec Medical Inc began with the idea of improving tumor treatments through electroporation. Electroporation is a process that uses electric pulses to increase the permeability of cell membranes. This facilitates the exchange of molecules and the uptake of drugs, which is used in the treatment of cancer cells. The business model of OncoSec Medical Inc is based on the development and commercialization of immunotherapies to combat cancer. Electroporation is used to locally infect tumor lesions with reactivated T-cells and other immune cells to generate an immune response. OncoSec Medical Inc has developed a proprietary platform called ImmunoPulse, which combines electroporation and immunotherapy. The company is divided into various divisions, including research and development, clinical trials, manufacturing, and distribution. Research and development focus on identifying potential immunotherapies and testing drug candidates. Clinical trials are designed to confirm the effectiveness and safety of therapies through clinical testing. Manufacturing involves the production of drug candidates and clinical preparations in accordance with Good Manufacturing Practices (GMPs). Distribution includes the sale and marketing of approved therapies to patients and healthcare providers. OncoSec Medical Inc offers a variety of immunotherapies for the treatment of various types of cancer. This includes ImmunoPulse IL-12 therapy, which is used to treat metastatic melanoma. The company is also working on several other therapies, including the Verapamil-Plus-IL-2 protocol for the treatment of breast and prostate cancer. In summary, OncoSec Medical Inc is an emerging biotechnology company specializing in the development and commercialization of immunotherapies to combat cancer. Through its proprietary ImmunoPulse platform and extensive research and development, the company strives to provide effective and safe treatment options for cancer patients, fully harnessing the potential of immunotherapy. OncoSec Medical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining OncoSec Medical's Employee Base

OncoSec Medical's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding OncoSec Medical's operational capacity and future potential.

Year-to-Year Comparison

Assessing OncoSec Medical's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

OncoSec Medical's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in OncoSec Medical’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about OncoSec Medical stock

How many employees does OncoSec Medical have this year?

OncoSec Medical has 42 undefined employees this year.

How many employees did OncoSec Medical have compared to the previous year?

Compared to the previous year, OncoSec Medical had 0% more employees.

What impact did the number of employees have on the company OncoSec Medical?

The number of employees has a direct impact on the efficiency and productivity of OncoSec Medical. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of OncoSec Medical?

The number of employees can also have an impact on investors of OncoSec Medical, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of OncoSec Medical affect the company?

An increase in equity of OncoSec Medical can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in OncoSec Medical's equity affect the company?

A reduction in equity of OncoSec Medical can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of OncoSec Medical?

Some factors that can influence the equity of OncoSec Medical include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of OncoSec Medical so important for investors?

The equity of OncoSec Medical is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at OncoSec Medical influence the company?

The number of employees at OncoSec Medical can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at OncoSec Medical evolved in recent years?

In recent years, the number of employees at OncoSec Medical has changed by 0.

How many employees does OncoSec Medical currently have?

OncoSec Medical currently has 42 undefined employees.

Why is the number of employees important for investors of OncoSec Medical?

The number of employees is important for investors of OncoSec Medical as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can OncoSec Medical take to change the number of employees?

To change the number of employees, OncoSec Medical can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does OncoSec Medical pay?

Over the past 12 months, OncoSec Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, OncoSec Medical is expected to pay a dividend of 0 USD.

What is the dividend yield of OncoSec Medical?

The current dividend yield of OncoSec Medical is .

When does OncoSec Medical pay dividends?

OncoSec Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of OncoSec Medical?

OncoSec Medical paid dividends every year for the past 0 years.

What is the dividend of OncoSec Medical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is OncoSec Medical located?

OncoSec Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von OncoSec Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of OncoSec Medical from 10/21/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/21/2024.

When did OncoSec Medical pay the last dividend?

The last dividend was paid out on 10/21/2024.

What was the dividend of OncoSec Medical in the year 2023?

In the year 2023, OncoSec Medical distributed 0 USD as dividends.

In which currency does OncoSec Medical pay out the dividend?

The dividends of OncoSec Medical are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The OncoSec Medical stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von OncoSec Medical

Our stock analysis for OncoSec Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of OncoSec Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.